Oppenheimer raises Amazon stock price target to $275 on AWS outlook

Oppenheimer lifted its Amazon price target to $275 from $260 and kept an Outperform rating, citing improving AWS expectations ahead of Q1 results on April 29. UBS, BMO Capital and Roth/MKM also raised targets to $304, $315 and $285 respectively, reflecting bullish views on AWS growth and Anthropic-related investment, though higher fuel costs and slower advertising growth remain near-term headwinds. The article also highlights Amazon’s expansion into electric trucking and weight management services via One Medical.

Analysis

The market is starting to re-rate AMZN as an AI infrastructure beneficiary rather than a retail compounder, and that shift matters more than the headline price target changes. If AWS capital spend is converted into durable revenue density, the upside is not just operating leverage — it also compresses the gap between Amazon’s valuation and higher-multiple software/platform peers that have less balance-sheet flexibility. The second-order effect is that every incremental proof point from AI workloads can trigger multiple expansion before the earnings model catches up.

The near-term setup is less about absolute beats and more about whether management can avoid another margin-guide disappointment. Into earnings, the stock is vulnerable to a classic “good story, wrong quarter” reaction if retail/fuel costs or capex intensity obscure the AWS acceleration narrative. The risk window is days, not months: positioning is already leaning constructive, so the bar for upside surprise is probably a cleaner commentary on 2H demand and capex conversion rather than a simple revenue beat.

The contrarian read is that the market may be underestimating how much Amazon’s strategic spend is pulling share from adjacent winners and losers. Higher AWS investment raises the odds that smaller cloud-adjacent beneficiaries get crowded out, while HIMS looks more exposed to Amazon’s healthcare bundling than the market may be pricing. On the flip side, WMT is not the direct victim here; if Amazon prioritizes margin repair and logistics efficiency over aggressive share capture, Walmart’s defensive multiple could hold.

The key question is whether the current premium to legacy retail peers is justified by a step-change in AWS monetization, or whether investors are paying upfront for growth that only arrives in 2026–27. If capex ramps faster than revenue per gigawatt, the whole thesis becomes a duration trap. If it holds, AMZN is one of the few megacaps where earnings revisions and multiple expansion can work together for several quarters.

Key Decisions for Investors

• Long AMZN into earnings with a 2-4 week horizon; prefer defined risk via call spread or small equity starter size. Risk/reward is attractive only if management explicitly supports AI-driven AWS acceleration and avoids fresh margin guide-downs.
• Pair trade: long AMZN / short HIMS for 1-3 months. Thesis: Amazon’s healthcare bundling can pressure HIMS customer acquisition and pricing power before the market fully discounts the competitive overlap.
• For investors already long AMZN, hedge event risk with a short-dated put spread into the print. This protects against a post-earnings multiple reset if guidance emphasizes capex and near-term margin drag.
• Avoid chasing UBS-style upside targets mechanically; wait for post-earnings confirmation. The better entry is on any 5-8% drawdown that is driven by near-term margin noise rather than AWS thesis deterioration.
• Relative-value long AMZN vs WMT only on a 6-12 month view if cloud growth is the primary driver. Near term, WMT remains the cleaner defensive holder if consumer weakness or fuel inflation pressures Amazon’s retail margin story.